Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search Results for: anti-kickback law

Cigna Sues HDL, Alleges Unlawful Fee Scheme

CEO SUMMARY: In court papers, Cigna alleged that HDL misrepresented patients’ responsibilities by promising not to collect co-payments, co-insurance, or deductibles. Also, HDL promised not to seek reimbursement from patients for any portion of its bills that the health insurer did not cover, the court documents show. HDL misleadingly billed the health insurer at exorbitant …

Cigna Sues HDL, Alleges Unlawful Fee Scheme Read More »

To access this post, you must purchase The Dark Report.

Florida Law Better Defines Lab Marketing Violations

CEO SUMMARY: Despite clear language in Florida’s new state law that bans the placement of laboratory employees in a physicians’ office, some clinical lab companies want to continue the practice of placing specimen collectors in physicians’ offices. These opinions were voiced by lab executives during a meeting on June 28 in Tallahassee, Florida, at the …

Florida Law Better Defines Lab Marketing Violations Read More »

To access this post, you must purchase The Dark Report.

In Florida, New Law Bans Certain Lab Sales Practices

CEO SUMMARY: Florida law has long prohibited clinical laboratories from giving kickbacks and other forms of remuneration to physicians to induce specimen referrals. Specifically, state regulations have prevented labs from placing specimen collectors in physicians’ offices. Despite these clear prohibitions, labs regularly violated state rules by placing specimen collectors and other lab employees in physicians’ …

In Florida, New Law Bans Certain Lab Sales Practices Read More »

To access this post, you must purchase The Dark Report.

Former Lab CEO Explains Why He Filed Lawsuit

CEO SUMMARY: It may be the first time that a former public laboratory CEO has turned whistleblower. Andrew Baker, formerly Chairman and CEO of Unilab Corporation in the 1990s, filed a qui tam case in federal court last year that centers on the practice of lab companies offering private health plans deeply-discounted lab test pricing …

Former Lab CEO Explains Why He Filed Lawsuit Read More »

To access this post, you must purchase The Dark Report.

Lawyers Provide Insights About Top Legal Concerns

CEO SUMMARY: After conducting the first-ever survey of the most important legal, compliance and managed care concerns for clinical labs and pathology groups, THE DARK REPORT asked leading lab industry attorneys who participated in the survey to say a few words about these topics. Here are useful nuggets of wisdom, advice, and insights about the …

Lawyers Provide Insights About Top Legal Concerns Read More »

To access this post, you must purchase The Dark Report.

New Federal Anti-kickback Investigation

POTENTIAL ANTI-KICKBACK VIOLATIONS in ancillary clinical service arrangements between referring physicians and providers like radiologists and laboratories continue to attract the interest of federal healthcare investigators. Right now, it appears radiology is a primary target. Last week, the Wall Street Journal disclosed that federal health investigators issued warrants and subpoenas to University MRI & Diagnostic …

New Federal Anti-kickback Investigation Read More »

To access this post, you must purchase The Dark Report.

UroCor’s Sales Tactics Violated Medicare Laws

CEO SUMMARY: By issuing a multi-count criminal indictment against three former UroCor executives, one federal attorney is creating new legal precedents for the laboratory industry. The criminal charges accuse UroCor of inducing physicians through such gambits as deeply-discounted pricing and “free testing” when not a contracted network laboratory. Labs should review compliance with these types …

UroCor’s Sales Tactics Violated Medicare Laws Read More »

To access this post, you must purchase The Dark Report.

Lawyer Argues: UroCor Charges Are a Concern

CEO SUMMARY: Criminal charges in the case against three ex-UroCor executives will likely alter existing compliance practices that affect how a lab offers price discounts to physicians and the way a lab uses “waiver of charges” in situations where it is an out-of-network provider. Attorney Jane Pine Wood was one of the first to see …

Lawyer Argues: UroCor Charges Are a Concern Read More »

To access this post, you must purchase The Dark Report.

Revised Stark and AKS Rules Are Good News for Labs

CEO SUMMARY: It must be rewarding for federal rulemakers at the Centers for Medicare and Medicaid Services and the Office of the Inspector General to hear that attorneys representing clinical labs and pathology groups consider the new final rules for the Stark Law and the Anti-Kickback Statute to be helpful for clarifying how labs and …

Revised Stark and AKS Rules Are Good News for Labs Read More »

To access this post, you must purchase The Dark Report.

Several Big Surprises in 2018’s Top 10 Lab Stories

CEO SUMMARY: This year’s list of the Top 10 Lab Industry Stories for 2018 is dominated by new directives from Medicare and private health insurers, as well as significant decisions by federal courts. Collectively, these developments create new compliance risks for all clinical laboratories and anatomic pathology groups. What is more notable about these top …

Several Big Surprises in 2018’s Top 10 Lab Stories Read More »

To access this post, you must purchase The Dark Report.

;